BENJAMIN WEYER: Open Payments
NPI 1962053579 · JASPER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$213 in 11 payments from 7 companies in 2025. Trend: 2023 $207 · 2024 $66 · 2025 $213
Food & beverage: $213
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $64 |
| Boston Scientific Corporation | 2 | $53 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
| Novo Nordisk Inc | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Amgen Inc. | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: LEQVIO, CDS - MCT/CEM Monitoring, JARDIANCE, Wegovy, EVKEEZA, REPATHA, TRINTELLIX.
Industry payments across IN — which companies pay providers there.
